CXCL12 and prostate cancer: Expression of α5β1 on prostate cancer cells is affected by a number of signalling pathways linked to tumour invasion and bone metastasis: the increase in cell adhesion to the endothelium caused by CXCL12 binding CXCR4 is a result of increased expression of α5 and β3 [71].